View a ticker or compare two or three
TRVI
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

TRVI is expected to report earnings to fall 1.82% to -10 cents per share on August 08

Trevi Therapeutics TRVI Stock Earnings Reports
Q2'24
Est.
$-0.11
Q1'24
Missed
by $0.02
Q4'23
Beat
by $0.01
Q3'23
Beat
by $0.01
Q2'23
Beat
by $0.02
The last earnings report on May 07 showed earnings per share of -10 cents, missing the estimate of -9 cents. With 189.61K shares outstanding, the current market capitalization sits at 187.36M.
A.I. Advisor
published General Information

General Information

a developer and manufacturer of neurological products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
195 Church Street
Phone
+1 203 304-2499
Employees
25
Web
https://www.trevitherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MABBX9.280.05
+0.54%
Morgan Stanley US Focus Real Estate C
GTSCX37.02-0.22
-0.59%
Glenmede Small Cap Equity Instl
GQFIX11.92-0.08
-0.67%
GQG Partners Global Quality Div Inc Ins
JSEQX58.30-0.48
-0.82%
JPMorgan Small Cap Equity R4
MPLAX13.43-0.15
-1.10%
Praxis International Index A

TRVI and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TRVI has been loosely correlated with ATNM. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TRVI jumps, then ATNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRVI
1D Price
Change %
TRVI100%
-2.07%
ATNM - TRVI
40%
Loosely correlated
-4.90%
TRDA - TRVI
33%
Loosely correlated
-3.60%
SCPH - TRVI
31%
Poorly correlated
-4.92%
KRYS - TRVI
31%
Poorly correlated
-0.60%
RNA - TRVI
30%
Poorly correlated
-3.32%
More